📄

Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?

active
paper Created: By: unknown Quality: 50% ✓ SciDEX ID: paper-38685916
📄 Paper Details
Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?
["Kuemper S", "Cairns A", "Birchall K", "Yao Z", "Large J"]
Frontiers in molecular neuroscience PubMed DOI
Abstract

Targeted protein degradation (TPD) is a rapidly expanding field, with various PROTACs (proteolysis-targeting chimeras) in clinical trials and molecular glues such as immunomodulatory imide drugs (IMiDs) already well established in the treatment of certain blood cancers. Many current approaches are focused on oncology targets, leaving numerous potential applications underexplored. Targeting proteins for degradation offers a novel therapeutic route for targets whose inhibition remains challenging,...

Metadata
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
5%
Debates
0
Incoming
1
Outgoing
1
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.